Campus activities

Biocitech has helped several high value-added scientific service companies set up offices and develop their businesses at the Park. Over time, there has been an accumulation of specialized skills in bioavailability studies, structural analysis, anatomopathology, bioinformatics, chemical synthesis and development procedures.

Biocitech has also financed and developed a shared evaluation laboratory that today is used by five firms. In the research process, drug candidate testing on animals is unavoidable. To have a regulatory-approved evaluation tool available on-site is a strong competitive advantage for the Park.

R&D activity:

  • Drug discovery: molecular characterization (Structuralis), molecular diagnostics (Oroxcell),
  • Chemistry: biological outflow processing (Eco-Solution), purification by high performance liquid chromatography (Kiralya), fine chemistry (Roowin), parallel synthesis (Chem-X-Infinity), detection of newly formed poisons (Spectralys Innovation),
  • Genetics: genome engineering (Cellectis)
  • Computing technology: scientific computing and robotic technologies (DiscnGine), computer aided molecular design (E&C), software (Sibio)
  • Non-medicinal health products (Alkapharm), applied research, non-medicinal health product expertise and hygiene products (Scientis)
  • Others: color analysis instruments (Ijina), experimental pathology studies (BiodOxis), robotics (Primadiag), press (Biotech. Info) and lobbying organization (Comité Adebiotech)

 

Pathologies studied :

  • Cancer : Endotis Pharma
  • Inflammatory diseases: Endotis Pharma
  • Infectious diseases: Mutabilis, Novexel, Pherecydes Pharma
  • Diseases of the bones and joints: Galapagos
  • Thrombosis: Endotis Pharma